Literature DB >> 11058755

Ex-FABP: a fatty acid binding lipocalin developmentally regulated in chicken endochondral bone formation and myogenesis.

F Descalzi Cancedda1, B Dozin, B Zerega, S Cermelli, R Cancedda.   

Abstract

Extracellular fatty acid binding protein (Ex-FABP) is a 21 kDa lipocalin specifically binding fatty acids, expressed during chicken embryo development in hypertrophic cartilage, in muscle fibers and in blood granulocytes. In chondrocyte and myoblast cultures Ex-FABP expression is increased by inflammatory agents and repressed by anti-inflammatory agents. In adult cartilage Ex-FABP is expressed only in pathological conditions such as in dyschondroplastic and osteoarthritic chickens. The possible mammalian counterpart is the Neu-related lipocalin (NRL), a lipocalin overexpressed in rat mammary cancer; NRL is homologous to the human neutrophil gelatinase associated lipocalin (NGAL) expressed in granulocytes and in epithelial cells in inflammation and malignancy and to the Sip24 (super-inducible protein 24), an acute phase lipocalin expressed in mouse after turpentine injection. Immunolocalization and in situ hybridization showed that NRL/NGAL is expressed in hypertrophic cartilage, in forming skeletal muscle fibers and in developing heart. In adult cartilage NRL/NGAL was expressed in articular cartilage from osteoarthritic patients and in chondrosarcoma. Moreover, NRL was induced in chondrocyte and myoblast cultures by an inflammatory agent. We propose that these lipocalins (Ex-FABP, NRL/NGAL, Sip24) represent stress proteins physiologically expressed in tissues where active remodeling is taking place during development and also present in tissues characterized by an acute phase response due to pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058755     DOI: 10.1016/s0167-4838(00)00159-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Synthesis of carbapyochelins via diastereoselective azidation of 5-(ethoxycarbonyl)methylproline derivatives.

Authors:  Wathsala Liyanage; Laksiri Weerasinghe; Roland K Strong; Juan R Del Valle
Journal:  J Org Chem       Date:  2008-08-13       Impact factor: 4.354

2.  Polymorphisms in chicken extracellular fatty acid binding protein gene.

Authors:  Zhi-yuan Zhao; Li Zhang; Bing-wang Du; Ning-xian Cao; Xin-sheng Jiang; Wen-xia Tian; Shu-jun Li; Wei-wei Wu; Chang-hui Ye
Journal:  Mol Biol Rep       Date:  2011-06-21       Impact factor: 2.316

3.  Transcriptome-based biomarker gene screening and evaluation of the extracellular fatty acid-binding protein (Ex-FABP) on immune and angiogenesis-related genes in chicken erythrocytes of tibial dyschondroplasia.

Authors:  Ali Raza Jahejo; Sayyad Ali Raza Bukhari; Nasir Rajput; Nazeer Hussain Kalhoro; Imdad Hussain Leghari; Sayed Haidar Abbas Raza; Zhen Li; Wen-Zhong Liu; Wen-Xia Tian
Journal:  BMC Genomics       Date:  2022-04-22       Impact factor: 4.547

4.  Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver.

Authors:  Vasanthi R Sunil; Kinal J Patel; Marit Nilsen-Hamilton; Diane E Heck; Jeffrey D Laskin; Debra L Laskin
Journal:  Exp Mol Pathol       Date:  2007-03-30       Impact factor: 3.362

5.  A lipocalin-derived Peptide modulating fibroblasts and extracellular matrix proteins.

Authors:  Linda Christian Carrijo-Carvalho; Durvanei A Maria; Janaina S Ventura; Kátia L P Morais; Robson L Melo; Consuelo Junqueira Rodrigues; Ana Marisa Chudzinski-Tavassi
Journal:  J Toxicol       Date:  2012-04-26

Review 6.  Antimicrobial Proteins and Peptides in Avian Eggshell: Structural Diversity and Potential Roles in Biomineralization.

Authors:  Thierry Moreau; Joël Gautron; Maxwell T Hincke; Philippe Monget; Sophie Réhault-Godbert; Nicolas Guyot
Journal:  Front Immunol       Date:  2022-07-27       Impact factor: 8.786

Review 7.  Siderocalins: Siderophore binding proteins evolved for primary pathogen host defense.

Authors:  Allyson K Sia; Benjamin E Allred; Kenneth N Raymond
Journal:  Curr Opin Chem Biol       Date:  2012-12-22       Impact factor: 8.822

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.